p -Cymene Complexes of Ruthenium(II) as Antitumor Agents

In this work, the cytotoxic behavior of six ruthenium(II) complexes of stoichiometry [(η - -cymene)RuCl L] (I-VI), L = 4-cyanopyridine (I), 2-aminophenol (II), 4-aminophenol (III), pyridazine (IV), and [( - -cymene)RuClL ]PF ; L = cyanopyridine (V), L = 2-aminophenol(VI) towards three cell lines was...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Molecules (Basel, Switzerland) Switzerland), 2020-10, Vol.25 (21), p.5063
Hauptverfasser: Pujante-Galián, María Angeles, Pérez, Sergio A, Montalbán, Mercedes G, Carissimi, Guzmán, Fuster, Marta G, Víllora, Gloria, García, Gabriel
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:In this work, the cytotoxic behavior of six ruthenium(II) complexes of stoichiometry [(η - -cymene)RuCl L] (I-VI), L = 4-cyanopyridine (I), 2-aminophenol (II), 4-aminophenol (III), pyridazine (IV), and [( - -cymene)RuClL ]PF ; L = cyanopyridine (V), L = 2-aminophenol(VI) towards three cell lines was studied. Two of them, HeLa and MCF-7, are human carcinogenic cells from cervical carcinoma and human breast cancer, respectively. A comparison with healthy cells was carried out with BGM cells which are monkey epithelial cells of renal origin. The behavior of complex II exhibits selectivity towards healthy cells, which is a promising feature for use in cancer treatment since it might reduce the side effects of most current therapies.
ISSN:1420-3049
1420-3049
DOI:10.3390/molecules25215063